Abstract:Objective SIRT 1 is a NAD+(nicotinmide nicotinamide adenine dinucleotide)-dependent deacetylase,which may be involved in the formation and progression of many types of carcinoma,and plays an important role in regulating protein function and gene silencing of certain tumor-related genes.The objective of the research is to investigate the clinicopathological significance of the expressions of SIRT 1,MLH 1 and E-cadherin in gastric cardia carcinoma and their relationship.Methods We detected the expressiond of SIRT 1,MLH 1 and E-cadherin proteins in the gastric cardia carcinoma tissues of 176 patients using the tissue microarray(TMA) technique and immunohistochemistry staining.Results The expression of SIRT 1 was positively correlated with lymph node metastasis(P=0.032) and TNM stages(P = 0.034),that of E-cadherin negatively with the histological differentiation(P=0.029),lymph node metastasis(P=0.000) and TNM stages(P=0.003),and that of MLH 1 showed no correlation with the clinicopathological features of gastric cardiac carcinoma,lymph node metastasis and TNM stages(P0.05).The complete follow-up data of 90 cases exhibited that the three-year survival rate and and mean survival time were significantly lower and shorter in the SIRT 1-positive than in the SIRT 1-negative patients(P=0.024),higher and longer in the patients with a strong positive E-cadherin expression than in those with a weak one(P=0.001),and higher and longer,too,in those with a positive MLH 1expression than in those with a negative one(P = 0.045).Conclusion The expression of SIRT 1 in gastric cardia carcinoma is associated with lymph node metastasis,TNM stages and survival time,but it is not an independent prognostic factor,and that of E-cadherin is negatively correlated with the degree of malignancy.SIRT 1 may promote the formation of gastric cardia carcinoma and influence its biological behavior by silencing tumor suppressor genes,such as E-cadherin and MLH 1.

Expression Of Sirt1 In Gastric Cardiac Cancer And Its Clinicopathologic Significance

Study on the Clinicopathologic Significance and Expression of SIRT1

Expressions of SIRT 1, E-cadherin and MLH 1 in Gastric Cardia Carcinoma and Their Relationship

Expressions of SIRT1 As Prognostic Biomarker on Resectable Gastric Cancer Patient

Expressions and clinical significance of Sirt1, P53 and P-gp in gastric carcinoma

Clinicopathological Significance of SIRT1 Expression in Colorectal Adenocarcinoma

SIRT1 Facilitates Hepatocellular Carcinoma Metastasis by Promoting PGC-1α-mediated Mitochondrial Biogenesis.

Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer.

Overexpression of SIRT1 is a Poor Prognostic Factor for Advanced Colorectal Cancer.

Expressions of FATI0 and P53 Mutant in Human Gastric Cancer and Their Relations

Overexpression of Sirtuin-1 is Associated with Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma

Meta-Analysis of Sirt1 Expression As A Prognostic Marker for Overall Survival in Gastrointestinal Cancer

High Levels of SIRT1 Expression Enhance Tumorigenesis and Associate with a Poor Prognosis of Colorectal Carcinoma Patients

Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.

The Prognostic Role of Sirt1-Autophagy Axis in Gastric Cancer

SIRT1 is a Regulator of Autophagy: Implications in Gastric Cancer Progression and Treatment

Study on the Different Expression of Molecular Markers Between Cardiac Cancer and Distal Gastric Cancer and Their Correlations with Clinicopathological Features

SIRT1 Inhibits Gastric Cancer Proliferation and Metastasis Via STAT3/MMP‐13 Signaling

Sirtuin 1, as a potential prognosis marker in clear cell renal cell carcinoma, regulates lipid metabolism and immune infiltration

SIRT3 Inhibits Cell Proliferation in Human Gastric Cancer Through Down-Regulation of Notch-1.

SIRT 3 Enhances Glycolysis and Proliferation in SIRT 3-Expressing Gastric Cancer Cells